Travel medicine and infectious disease · 2026
Impact of the COVID-19 pandemic on travel medicine services in Taiwan, 2019-2022.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Huang Szu-Hsuan, Lin Yung-Ching, Shih Yi-Li, Kuo Jiun-Shian, Ho Li-Li
Аннотация
BACKGROUND: The COVID-19 pandemic profoundly disrupted international travel and travel medicine services worldwide. Few studies have examined nationwide trends. We analyzed travel clinic visits and travel medicine services in Taiwan across the pandemic to assess its impact and inform future policy and preparedness planning.
METHODS: This population-based longitudinal study utilized nationwide data from Travel Medicine Contract Hospitals from 2019 to 2022. The number of travel clinic visits, travel vaccinations, and International Certificate of Vaccination or Prophylaxis (ICVP) issuance were compared between 2019 and subsequent years using paired sample t-tests.
RESULTS: During 2019-2022, 218,700 travel clinic visits, 92,218 travel vaccine doses, and 162,653 ICVPs were recorded. Clinic visits decreased by 52 % in 2020 but increased by 80 % in 2021 and 143 % in 2022, exceeding pre-pandemic levels. Travel vaccinations decreased by 70 % in 2020, increased by 229 % in 2021, and then decreased slightly by 22 % in 2022. ICVP issuance dropped by 74 % in 2020 but rose more than fivefold by 2022. The surge in travel vaccinations and ICVP issuance in 2021-2022 was mainly attributed to COVID-19 vaccinations and free yellow fever and meningococcal conjugate vaccination campaigns. The most documented vaccine in ICVPs shifted from yellow fever vaccines to COVID-19 vaccines during 2021-2022.
CONCLUSIONS: The pandemic reshaped Taiwan's travel medicine landscape. Coordinated government-hospital efforts enabled timely vaccine allocation, minimized wastage, and maintained service capacity. These results underscore the need for flexible vaccination strategies and the transition toward digital health documentation for future preparedness.
METHODS: This population-based longitudinal study utilized nationwide data from Travel Medicine Contract Hospitals from 2019 to 2022. The number of travel clinic visits, travel vaccinations, and International Certificate of Vaccination or Prophylaxis (ICVP) issuance were compared between 2019 and subsequent years using paired sample t-tests.
RESULTS: During 2019-2022, 218,700 travel clinic visits, 92,218 travel vaccine doses, and 162,653 ICVPs were recorded. Clinic visits decreased by 52 % in 2020 but increased by 80 % in 2021 and 143 % in 2022, exceeding pre-pandemic levels. Travel vaccinations decreased by 70 % in 2020, increased by 229 % in 2021, and then decreased slightly by 22 % in 2022. ICVP issuance dropped by 74 % in 2020 but rose more than fivefold by 2022. The surge in travel vaccinations and ICVP issuance in 2021-2022 was mainly attributed to COVID-19 vaccinations and free yellow fever and meningococcal conjugate vaccination campaigns. The most documented vaccine in ICVPs shifted from yellow fever vaccines to COVID-19 vaccines during 2021-2022.
CONCLUSIONS: The pandemic reshaped Taiwan's travel medicine landscape. Coordinated government-hospital efforts enabled timely vaccine allocation, minimized wastage, and maintained service capacity. These results underscore the need for flexible vaccination strategies and the transition toward digital health documentation for future preparedness.